Results from a new study published in Clinical and Translational Immunology found that dual-target antibody therapy can enhance cancer-fighting T cells more effectively than current single-target ...

She noted the survival benefit with the combination was achieved even though 38% of patients in the enzalutamide-alone arm ...

Prostate-specific antigen responses were similar between transdermal estradiol and hormone therapy combined with androgen receptor inhibitors in prostate cancer.

An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...

Responses were similar among patients with estrogen patches and ARPIs compared to luteinizing hormone releasing hormone ...

Women whose breast cancers need estrogen to grow are often treated for five or more years with medications to lower estrogen production or block its effects. Broadly known as endocrine therapy, the ...

Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...

Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.

Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of ...

Captain ‘Wild’ Bill Wichrowski, known for his role on Discovery Channel’s Deadliest Catch, has provided an encouraging update on his battle with prostate cancer. In a recent statement, he shared that ...

Patients with mHSPC benefited from darolutamide + ADT + docetaxel irrespective of age (<75 years and ≥75 years), with consistent improvements in overall survival, time to mCRPC, and time to initiation ...

Chhavi Mittal, who was diagnosed with early-stage breast cancer in 2022, took a toll on the criticism she received for her ...